| Literature DB >> 21211054 |
Geneviève Cadieux1, David L Buckeridge, André Jacques, Michael Libman, Nandini Dendukuri, Robyn Tamblyn.
Abstract
BACKGROUND: Community clinics offer potential for timelier outbreak detection and monitoring than emergency departments. However, the accuracy of syndrome definitions used in surveillance has never been evaluated in community settings. This study's objective was to assess the accuracy of syndrome definitions based on diagnostic codes in physician claims for identifying 5 syndromes (fever, gastrointestinal, neurological, rash, and respiratory including influenza-like illness) in community clinics.Entities:
Mesh:
Year: 2011 PMID: 21211054 PMCID: PMC3025839 DOI: 10.1186/1471-2458-11-17
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Population-based, 3-stage stratified random sample of visits to all community physicians in the province of Quebec.
Figure 2Overview of data collection
* Physician sampling by the Quebec health insurance agency is described in Figure 1, Stages 1 and 2.
** Visit sampling by the research team is described in Figure 1, Stage 3.
Characteristics of participating and non-participating physicians
| Participating physicians (N = 1,098) | Non-participating physicians (N = 2,160) | |||
|---|---|---|---|---|
| Gender: | ||||
| Female | 411 | 37.4 | 823 | 38.1 |
| Male | 687 | 62.6 | 1,337 | 61.9 |
| Preferred language: | ||||
| French | 1,006 | 91.6 | 1,937 | 89.7 |
| English | 92 | 8.4 | 223 | 10.3 |
| Specialty: | ||||
| General practice | 993 | 90.4 | 1,932 | 89.4 |
| Internal medicine | 13 | 1.2 | 41 | 1.9 |
| Pediatrics | 62 | 5.6 | 102 | 4.7 |
| General surgery | 30 | 2.7 | 85 | 3.9 |
| Geriatrics | 0 | 0 | 0 | 0 |
| Type of setting selected:1 | ||||
| Private clinic | 1,060 | 96.5 | 2,044 | 94.6 |
| Community health center | 5 | 0.5 | 9 | 0.4 |
| Hospital-based | 33 | 3.0 | 107 | 5.0 |
| Geographic location of selected setting:1,3 | ||||
| Urban | 921 | 83.9 | 1,867 | 86.4 |
| Rural | 177 | 16.1 | 293 | 13.6 |
| Years since licensure | 24.2 | 9.7 | 22.3 | 10.5 |
| No. days worked per year1 | 157.0 | 55.0 | 143.2 | 59.8 |
| No. patients seen per day worked1 | 21.2 | 13.4 | 21.0 | 13.3 |
| Fever | 80,884 | 11 | 160,821 | 12 |
| Gastrointestinal | 162,282 | 22 | 309,209 | 24 |
| Neurological | 40,236 | 5 | 73,810 | 6 |
| Rash | 126,900 | 17 | 224,370 | 17 |
| Respiratory | 911,924 | 125 | 1,643,240 | 126 |
| Fever | 162,000 | 22 | 291,990 | 22 |
| Gastrointestinal | 146,355 | 20 | 283,578 | 22 |
| Neurological | 36,344 | 5 | 67,344 | 5 |
| Rash | 55,251 | 8 | 103,698 | 8 |
| Respiratory | 478,201 | 65 | 877,556 | 67 |
| Large-group | 622,046 | 85 | 1,129,782 | 87 |
| Small-group | 32,173 | 4 | 61,127 | 5 |
1 As per our study design, for each physician, a single practice location was randomly selected to facilitate the validation process. The information in this table is based in claims generated from the selected practice location during the 2-year study period.
2 There were a total of 7,315,994 visits to the 1,098 participating physicians, and 13,010,410 visits to the 2,160 eligible non-participating physicians at the selected practice location during the 2-year study period.
3 We tested the statistical significance (at the p < 0.05 level) of any differences between participating and non-participating physicians using a multivariate logistic regression model where the dependent variable was participation and the independent variables were all characteristics in Table 1. Due to overlap between CDC, RODS, and ILI syndrome definitions, to avoid collinearity, we used separate models for each set of syndrome definitions. As compared to non-participating physicians, participating physicians had been in practice longer (odds ratio (OR)per 10 years since licensure, 1.15; 95% CI, 1.05-1.25), had worked more days (ORper 50 days, 1.18; 95% CI, 1.09-1.28) during the 2-year study period.
4 Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of Defense's Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
5 Syndrome case definitions developed in the context of the University of Pittsburgh's Real-time Outbreak and Disease Surveillance (RODS) system.
6 Syndrome case definitions developed in the context of the US Department of Defense's Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
Accuracy of ICD-9 coded diagnoses in physician claims, as compared to ICD-9 coded diagnoses from physician-facilitated medical chart review, for identifying constitutional, gastrointestinal, neurological, rash, and respiratory syndrome, as well as influenza-like illness (ILI) (N = 10,529 visits with matched claim-record pair)
| Syndrome definition | Sensivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | ||
|---|---|---|---|---|---|---|
| Fever | 601 | 656 | 0.11 (0.10, 0.13) | 0.99 (0.99, 0.99) | 0.59 (0.55, 0.64) | 0.94 (0.93, 0.95) |
| Gastrointestinal | 855 | 888 | 0.23 (0.20, 0.26) | 0.99 (0.99, 0.99) | 0.71 (0.66, 0.75) | 0.94 (0.94, 0.95) |
| Neurological | 971 | 693 | 0.17 (0.14, 0.21) | 1.00 (1.00, 1.00) | 0.67 (0.64, 0.70) | 0.98 (0.98, 0.98) |
| Rash | 897 | 905 | 0.20 (0.18, 0.23) | 0.99 (0.99, 0.99) | 0.66 (0.62, 0.70) | 0.95 (0.95, 0.96) |
| Respiratory | 1,049 | 1,779 | 0.44 (0.41, 0.47) | 0.97 (0.96, 0.98) | 0.85 (0.83, 0.88) | 0.84 (0.83, 0.85) |
| Fever | 873 | 961 | 0.14 (0.12, 0.16) | 0.99 (0.99, 0.99) | 0.60 (0.56, 0.64) | 0.91 (0.90, 0.92) |
| Gastrointestinal | 703 | 834 | 0.20 (0.18, 0.23) | 0.99 (0.99, 0.99) | 0.68 (0.63, 0.73) | 0.94 (0.94, 0.95) |
| Neurological | 874 | 523 | 0.16 (0.13, 0.20) | 1.00 (1.00, 1.00) | 0.52 (0.48, 0.55) | 0.99 (0.98, 0.99) |
| Rash | 814 | 718 | 0.12 (0.10, 0.14) | 1.00 (1.00, 1.00) | 0.63 (0.59, 0.66) | 0.96 (0.96, 0.97) |
| Respiratory | 665 | 1,209 | 0.29 (0.26, 0.32) | 0.98 (0.98, 0.98) | 0.74 (0.70, 0.79) | 0.87 (0.86, 0.88) |
| Large-group | 653 | 1,232 | 0.38 (0.35, 0.41) | 0.98 (0.98, 0.98) | 0.77 (0.73, 0.81) | 0.88 (0.87, 0.89) |
| Small-group | 53 | 49 | 0.18 (0.12, 0.26) | 1.00 (1.00, 1.00) | 0.29 (0.16, 0.41) | 0.99 (0.99, 0.99) |
1 Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of Defense's Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
2 Syndrome case definitions developed in the context of the University of Pittsburgh's Real-time Outbreak and Disease Surveillance (RODS) system.
3 Syndrome case definitions developed in the context of the US Department of Defense's Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
Example of diagnostic codes with the highest and lowest positive predictive value (excerpted from additional file 1)
| Fever1 | 82.8 | Tick-borne rickettsiosis not elsewhere classified | 1.00 (1.00, 1.00) |
| 88.8 | Other specified arthropod-borne diseases | 1.00 (1.00, 1.00) | |
| Gastrointestinal1 | 7.1 | Giardiasis | 1.00 (1.00, 1.00) |
| 5.9 | Food poisoning not otherwise specified | 1.00 (1.00, 1.00) | |
| Neurological1 | 323.0 | Encephalitis in viral disease classified elsewhere | 1.00 (1.00, 1.00) |
| 784.3 | Aphasia | 1.00 (1.00, 1.00) | |
| Rash1 | 53.8 | Herpes zoster with unspecified complication | 1.00 (1.00, 1.00) |
| 695.2 | Erythema nodosum | 1.00 (1.00, 1.00) | |
| Respiratory1 | 33.0 | 1.00 (1.00, 1.00) | |
| 462.9 | Pharyngitis, acute not otherwise specified | 1.00 (1.00, 1.00) | |
| ILI large-group2 | 487.0 | Influenza with pneumonia | 1.00 (1.00, 1.00) |
| 486.0 | Pneumonia, organism not otherwise specified | 1.00 (1.00, 1.00) | |
| Fever1 | 88.0 | Bartonellosis | 0.00 (0.00, 0.00) |
| 78.2 | Sweating fever | 0.00 (0.00, 0.00) | |
| Gastrointestinal1 | 555.0 | Regional enteritis, small intestine | 0.00 (0.00, 0.00) |
| 1.1 | Cholera due to | 0.00 (0.00, 0.00) | |
| Neurological1 | 323.2 | Encephalitis in protozoal disease classified elsewhere | 0.00 (0.00, 0.00) |
| 53.0 | Herpes zoster with meningitis | 0.00 (0.00, 0.00) | |
| Rash1 | 51.0 | Cowpox | 0.00 (0.00, 0.00) |
| 55.8 | Measles complications not otherwise specified | 0.00 (0.00, 0.00) | |
| Respiratory1 | 20.4 | Secondary pneumonic plague | 0.00 (0.00, 0.00) |
| 79.8 | Hantavirus infection | 0.00 (0.00, 0.00) | |
| ILI large-group2 | 490.0 | Bronchitis not otherwise specified | 0.00 (0.00, 0.00) |
| 465.8 | Acute upper respiratory infection, other multiple sites | 0.36 (0.08, 0.65) | |
1 Syndrome case definitions developed and published by the US Centers for Disease Control and Prevention (CDC) in 2003, and used by the US Department of Defense's Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).
2 Syndrome case definition developed in the context of the US Department of Defense's Electronic Surveillance System for Early Notification of Community-based Epidemics (ESSENCE).